CareDx Reports Fourth Quarter and Full Year 2022 Results

Go back to CareDx Reports Fourth Quarter and Full Year 2022 Results

CareDx (CDNA) Tops Q4 EPS by 26c; Offers FY23 Revenue Guidance

February 27, 2023 4:05 PM EST

CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.07), $0.26 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $82.4 million versus the consensus estimate of $81.67 million.

GUIDANCE:

CareDx sees FY2023 revenue of $328-338 million, versus the consensus of $321... More